Interim report, January-June 2001
Interim report, January-June 2001 · Group sales totalled SEK 5.0 M (SEK 4.4 M). · The result after net interest income/expense was SEK -20.4 M (SEK 14.5 M). · Carisolvtm was approved by the FDA in the USA. · MediTeam is implementing strategic changes. · Operations are being extended by the sale of new dental products. Sales and results The group's sales for the period totalled SEK 5.0 million (SEK 4.4 million). Sales during the second quarter totalled SEK 2.7 million (SEK 2.2 million). Sales of the multimix gel packaging increased from 4,400 during the first half of 2000 to 5,400 during the